Bone Mineral Density Study In Patients With Chronic Obstructive Pulmonary Disease. DISKUS® Inhaler is a Trademark of the GSK Group of Companies.

Completed · Phase 4

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

This study will last up to 3 years. You will visit the clinic up to 14 times. Certain visits will include lung function tests and scans of your bones. The purpose of this study is to determine the effect of the steroid component of an inhaled product on bone mineral density in patients with Chronic Obstructive Pulmonary Disease (COPD).

Key facts

Study ID

NCT00355342

Run by

GlaxoSmithKline

People needed

186

Starts

2004-04-28

Expected to finish

2007-09-06

Last updated by the study team

2018-07-02

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Established clinical history of COPD.
• Baseline FEV1 <70% predicted normal, and FEV1/FVC ratio of less than 70%.
• Smoking history of at least 10 pack-years, where both current and former smokers will be eligible.
• Must have at least one native, evaluable hip.

You may not qualify if…

• History of or evidence for metabolic bone diseases other than osteoporosis or osteopenia.

Where it is running

• GSK Investigational Site — Berkeley, California, United States
• GSK Investigational Site — Fullerton, California, United States
• GSK Investigational Site — Rancho Mirage, California, United States
• GSK Investigational Site — San Diego, California, United States
• GSK Investigational Site — Walnut Creek, California, United States
• GSK Investigational Site — Fort Collins, Colorado, United States
• GSK Investigational Site — Wheat Ridge, Colorado, United States
• GSK Investigational Site — Hartford, Connecticut, United States
• GSK Investigational Site — Fort Lauderdale, Florida, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Sarasota, Florida, United States
• GSK Investigational Site — Tamarac, Florida, United States
• GSK Investigational Site — Atlanta, Georgia, United States
• GSK Investigational Site — Chicago, Illinois, United States
• GSK Investigational Site — North Chicago, Illinois, United States
• GSK Investigational Site — Wichita, Kansas, United States
• GSK Investigational Site — Boston, Massachusetts, United States
• GSK Investigational Site — Cadillac, Michigan, United States
• GSK Investigational Site — Saint Charles, Missouri, United States
• GSK Investigational Site — Omaha, Nebraska, United States
• GSK Investigational Site — Bronxville, New York, United States
• GSK Investigational Site — Charlotte, North Carolina, United States
• GSK Investigational Site — Portland, Oregon, United States
• GSK Investigational Site — Charleston, South Carolina, United States
• GSK Investigational Site — Greer, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.